◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Xtrackers ShortDAX x2 Daily Swap UCITS ETF 1C (XSD2) ETF Overview

Name: Xtrackers ShortDAX x2 Daily Swap UCITS ETF 1C (XSD2) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-01

Xtrackers ShortDAX x2 Daily Swap UCITS ETF 1C (XSD2) is an exchange-traded fund managed by DWS Investment S.A. (ETF). It manages roughly £64 million in assets.

Interactive chart & fund stats →

XSD2 Fund Statistics

Expense ratio	0.60%
Assets under management	£64 million
Fund family	DWS Investment S.A. (ETF)
Inception	2010-03-18

The live price chart, fund profile and news are in the interactive XSD2 viewer.

Other Companies in —

EUSP · Global X European Superdividend UCITS ETF EUR Distribution — £64 million
LDME · L&G Emerging Markets Quality Dividends Equal Weight ETF USD Dis — £64 million
LGGM · L&G Emerging Markets Quality Dividends Equal Weight ETF USD Dis — €64 million
DBPD · Xtrackers ShortDAX x2 Daily Swap UCITS ETF 1C — €64 million
CHSV · UBS Core BBG US Treasury 1-10 UCITS ETF USD acc — €63 million
UB82 · UBS Core BBG US Treasury 1-10 UCITS ETF USD dis — £63 million
UEFI · UBS Core BBG US Treasury 1-10 UCITS ETF USD dis — €63 million
AW10 · UBS MSCI World ex USA Climate Paris Aligned UCITS ETF USD acc — €63 million

← XSD All “X” companies XSDR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.